Effect of GM-CSF on cytokine induction by soluble β-glucan SCG in vitro in β-glucan-treated mice

Microbiology and Immunology

Volumn 53, Issue 7, 2009, Pages 391-402

  Hida, Toshie H ^a   Kawaminami, Hiromi ^a   Ishibashi, Ken Ichi ^a   Miura, Noriko N ^a   Adachi, Yoshiyuki ^a   Yadomae, Toshiro ^a   Ohno, Naohito ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

glucan; GM CSF; IFN ; TNF

Indexed keywords

BETA GLUCAN; DECTIN 1; GENTAMICIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SGC; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL COUNT; CELL CULTURE; CELL POPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DBA 1 MOUSE; DBA 2 MOUSE; DRUG EFFECT; DRUG MECHANISM; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CYTOLOGY; DBA MOUSE; IMMUNOLOGY; METABOLISM; SOLUBILITY; SPECIES DIFFERENCE; SPLEEN;

FUNGI; MUS;

ANIMALS; BETA-GLUCANS; CELLS, CULTURED; CYTOKINES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERFERON-GAMMA; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; SOLUBILITY; SPECIES SPECIFICITY; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70149083280     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2009.00139.x     Document Type: Article

References (28)

1. Herre J., Gordon S., Brown G.D. (2004) Dectin-1 and its role in the recognition of beta-glucans by macrophages. Mol Immunol 40: 869-76.
2. Yadomae T., Ohno N. (1996) Structure-activity relationship of immunomodulating (1->3)-beta-D-glucans. Recent Res Devel Chem Pharm Sci 1: 23-33.
3. Adachi Y., Ishii T., Ikeda Y., Hoshino A., Tamura H., Aketagawa J., Tanaka S., Ohno N. (2004) Characterization of beta-glucan recognition site on C-type lectin, dectin 1. Infect Immun 72: 4159-71.
4. Dennehy K.M., Brown G.D. (2007) The role of the beta-glucan receptor Dectin-1 in control of fungal infection. J Leukoc Biol 82: 253-8.
5. Saijo S., Fujikado N., Furuta T., Chung S.H., Kotaki H., Seki K., Sudo K., Akira S., Adachi Y., Ohno N., Kinjo T., Nakamura K., Kawakami K., Iwakura Y. (2007) Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat Immunol 8: 39-46.
6. Hamuro J., Röllinghoff M.,Wagner H. (1980) Induction of cytotoxic peritoneal exudate cells by T-cell immune adjuvants of the beta(1 leads to 3) glucan-type lentinan and its analogues. Immunology 39: 551-9.
7. Hamuro J., Röllinghoff M.,Wagner H. (1978) beta(1 leads to 3) Glucan-mediated augmentation of alloreactive murine cytotoxic T-lymphocytes in vivo. Cancer Res 38: 3080-5.
8. Hamuro J., Hadding U., Bitter-Suermann D. (1978) Solid phase activation of alternative pathway of complement by beta-1,3-glucans and its possible role for tumour regressing activity. Immunology 34: 695-705.
9. Fujimoto S., Orita K., Kimura T., Kondo T., Taguchi T., Yoshida K., Ogawa N., Furue H. (1983) [Clinical evaluation of SPG (schizophyllan) as a therapeutic adjuvant after surgery of gastric cancer-controlled study by an envelope method]. Gan To Kagaku Ryoho 10: 1135-45.
10. Hong F., Yan J., Baran J.T., Allendorf D.J., Hansen R.D., Ostroff G.R., Xing P.X., Cheung N.K., Ross G.D. (2004). Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J Immunol 173: 797-806.
11. Tada R., Harada T., Nagi-Miura N., Adachi Y., Nakajima M., Yadomae T., Ohno N. (2007) NMR characterization of the structure of a beta-(1->3)-D- glucan isolate from cultured fruit bodies of Sparassis crispa. Carbohydr Res 342: 2611-8.
12. Harada T., Miura N.N., Adachi Y., Nakajima M., Yadomae T., Ohno N. (2002) Effect of SCG, 1,3-β-D-glucan from Sparassis crispa on the hematopoietic response in cyclophosphamide induced leukopenic mice. Biol Pharm Bull 25: 931-9.
13. Ohno N., Miura N.N., Nakajima M., Yadomae T. (2000). Antitumor 1,3-beta-glucan from cultured fruit body of Sparassis crispa. Biol Pharm Bull 23: 866-72.
14. Harada T., Kawaminami H., Miura N.N., Adachi Y., Nakajima M., Yadomae T., Ohno N. (2006). Comparison of the immunomodulating activities of 1,3-β-glucan fractions from culinary-medicinal mushroom, Sparassis crispa Wulf.:Fr. (Aphyllophoromycetideae). Int J Medicinal Mushrooms 8: 231-44.
15. Ohno N., Nameda S., Harada T., Miura N.N., Adachi Y., Nakajima M., Yoshida K., Yoshida H., Yadomae T. (2003) Immunomodulating activity of a β-glucan preparation, SCG, extracted from a culinary-medicinal mushroom, Sparassis crispa Wulf.:Fr. (Aphyllophoromycetideae), and application to cancer patients. Int J Medicinal Mushrooms 5: 373-81.
16. Harada T., Masuda S., Arii M., Adachi Y., Nakajima M., Yadomae T., Ohno N. (2005) Soy isoflavone aglycone modulates a hematopoietic response in combination with soluble beta-glucan: SCG. Biol Pharm Bull 28: 2342-5.
17. Ohno N., Harada T., Masuzawa S., Miura N.N., Adachi Y., Nakajima M., Yadomae T. (2002) Antitumor activity and hematopoietic response of β-glucan extracted from an edible and medicinal mushroom Sparassis crispa wulf.:Fr (Aphyllophoromycetideae). Int J Medicinal Mushrooms 4: 13-26.
18. Nameda S., Harada T., Miura N.N., Adachi Y., Yadomae T., Nakajima M., Ohno N. (2003) Enhanced cytokine synthesis of leukocytes by a β-glucan preparation, SCG, extracted from a medicinal mushroom, Sparassis crispa. Immunopharmacol Immunotoxicol 25: 321-35.
19. Harada T., Miura N.N., Adachi Y., Nakajima M., Yadomae T., Ohno N. (2002) IFN-gamma induction by SCG, 1,3-beta-D-glucan from Sparassis crispa, in DBA/2mice in vitro. J Interferon Cytokine Res 22: 1227-39.
20. Harada T., Miura N.N., Adachi Y., Nakajima M., Yadomae T., Ohno N. (2008) Highly expressed dectin-1 on bone marrow-derived dendritic cells regulates the sensitivity to beta-glucan in DBA/2 mice. J Interferon Cytokine Res 28: 477-86.
21. Harada T., Nagi Miura N., Adachi Y., Nakajima M., Yadomae T., Ohno N. (2003) Antibody to soluble 1,3/1,6-beta-D-glucan, SCG in sera of naive DBA/2 mice. Biol Pharm Bull 26: 1225-8.
22. Harada T., Ohno N. (2008) Contribution of dectin-1 and granulocyte macrophage-colony stimulating factor (GM-CSF) to immunomodulating actions of beta-glucan. Int Immunopharmacol 8: 556-66.
23. Harada T., Kawaminami H., Miura N.N., Adachi Y., Nakajima M., Yadomae T., Ohno N. (2006) Mechanism of enhanced hematopoietic response by soluble beta-glucan SCG in cyclophosphamide-treated mice. Microbiol Immunol 50: 687-700.
24. Harada T., Kawaminami H., Miura N.N., Adachi Y., Nakajima M., Yadomae T., Ohno N. (2006) Cell to cell contact through ICAM-1-LFA-1 and TNF-alpha synergistically contributes to GM-CSF and subsequent cytokine synthesis in DBA/2 mice induced by 1,3-beta-D-Glucan SCG. J Interferon Cytokine Res 26: 235-47.
25. Rosas M., Gordon S., Taylor P.R. (2007) Characterisation of the expression and function of the GM-CSF receptor alpha-chain in mice. Eur J Immunol 37: 2518-28.
26. Adachi Y., Okazaki M., Ohno N., Yadomae T. (1994) Enhancement of cytokine production by macrophages stimulated with (1->3)-beta-D-glucan, grifolan (GRN), isolated from Grifola frondosa. Biol Pharm Bull 17: 1554-60.
27. Ohno N., Asada N., Adachi Y., Yadomae T. (1995) Enhancement of LPS triggered TNF-alpha (tumor necrosis factor-alpha) production by (1->3)-beta-D-glucans in mice. Biol Pharm Bull 18: 126-33.
28. Ozment-Skelton T.R., Goldman M.P., Gordon S., Brown G.D., Williams D.L. (2006) Prolonged reduction of leukocyte membrane-associated Dectin-1 levels following beta-glucan administration. J Pharmacol Exp Ther 318: 540-6.